Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Shield

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Transplantation|October 1, 1988
Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejectionD J Norman, C F Shield, K R Henell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2007
Long-term survival of kidneys transplanted from live A2 donors to O and B recipientsC F Bryan, P W Nelson, C F Shield, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1996
Improved graft survival in cadaveric renal retransplantation by flow crossmatchingP W Nelson, P Eschliman, C F Shield, et al.
Clinical Transplantation|March 21, 2002
The influence of age, gender and ethnicity on cadaveric organ recovery rateP W Nelson, M I Aeder, W Andrews, et al.
Progress in Clinical and Biological Research|January 1, 1986
OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatmentsG Goldstein, D J Norman, C F Shield, et al.
JAMA|January 8, 1992
Factors affecting the waiting time of cadaveric kidney transplant candidates in the United StatesF P Sanfilippo, W K Vaughn, T G Peters, et al.
Transplantation|February 1, 1988
Successful transplantation of blood group A2 kidneys into non-A recipientsP W Nelson, T S Helling, G E Pierce, et al.
Transplantation Proceedings|December 1, 1993
Incidence of a positive final antiglobulin (AHG) T-cell crossmatch in patients waiting for cadaveric renal transplantation is not influenced by race of recipientC F Bryan, M I Aeder, A M Luger, et al.
Transplantation Proceedings|December 1, 1992
Influence of race, PRA level, and gender on the incidence of a positive donor-specific preliminary T cell crossmatchC F Bryan, M I Aeder, T S Helling, et al.
Transplantation Proceedings|December 1, 1993
Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocationC F Bryan, K Harrell, M I Aeder, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Transplantation|October 1, 1988
Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejectionD J Norman, C F Shield, K R Henell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2007
Long-term survival of kidneys transplanted from live A2 donors to O and B recipientsC F Bryan, P W Nelson, C F Shield, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1996
Improved graft survival in cadaveric renal retransplantation by flow crossmatchingP W Nelson, P Eschliman, C F Shield, et al.
Clinical Transplantation|March 21, 2002
The influence of age, gender and ethnicity on cadaveric organ recovery rateP W Nelson, M I Aeder, W Andrews, et al.
Progress in Clinical and Biological Research|January 1, 1986
OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatmentsG Goldstein, D J Norman, C F Shield, et al.
JAMA|January 8, 1992
Factors affecting the waiting time of cadaveric kidney transplant candidates in the United StatesF P Sanfilippo, W K Vaughn, T G Peters, et al.
Transplantation|February 1, 1988
Successful transplantation of blood group A2 kidneys into non-A recipientsP W Nelson, T S Helling, G E Pierce, et al.
Transplantation Proceedings|December 1, 1993
Incidence of a positive final antiglobulin (AHG) T-cell crossmatch in patients waiting for cadaveric renal transplantation is not influenced by race of recipientC F Bryan, M I Aeder, A M Luger, et al.
Transplantation Proceedings|December 1, 1992
Influence of race, PRA level, and gender on the incidence of a positive donor-specific preliminary T cell crossmatchC F Bryan, M I Aeder, T S Helling, et al.
Transplantation Proceedings|December 1, 1993
Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocationC F Bryan, K Harrell, M I Aeder, et al.
Pageof 9